How to more efficiently study complex treatment interactions
A new approach for testing multiple treatment combinations at once could help scientists develop drugs for cancer or genetic disorders.
A new approach for testing multiple treatment combinations at once could help scientists develop drugs for cancer or genetic disorders.
A first-of-its-kind study in mice shows neurons add and shed synapses at a frenzied pace during development to integrate visual signals from the two eyes.
CellLENS reveals hidden patterns in cell behavior within tissues, offering deeper insights into cell heterogeneity — vital for advancing cancer immunotherapy.
The approach collects multiple types of imaging and sequencing data from the same cells, leading to new insights into mouse liver biology.
Watery fluid between cells plays a major role, offering new insights into how organs and tissues adapt to aging, diabetes, cancer, and more.
Modern-day analogs in Antarctica reveal ponds teeming with life similar to early multicellular organisms.
The method could help predict whether immunotherapies will work in a patient or how a tumor will respond to drug treatment.
Trained with a joint understanding of protein and cell behavior, the model could help with diagnosing disease and developing new drugs.
The MESA method uses ecological theory to map cellular diversity and spatial patterns in tissues, offering new insights into disease progression.
Ultraviolet light “fingerprints” on cell cultures and machine learning can provide a definitive yes/no contamination assessment within 30 minutes.
The technology, which achieves single-cell resolution, could help in continuous, noninvasive patient assessment to guide medical treatments.
Since an MIT team introduced expansion microscopy in 2015, the technique has powered the science behind kidney disease, plant seeds, the microbiome, Alzheimer’s, viruses, and more.
CAMP4 Therapeutics is targeting regulatory RNA, whose role in gene expression was first described by co-founder and MIT Professor Richard Young.
The research may enable the design of synthetic, light-activated cells for wound healing or drug delivery.
MIT engineers developed a way to grow artificial tissues that look and act like their natural counterparts.